Project

Synthetic glyco-biotechnology: arming therapeutic CAR-T cells with glyco-engineered suppressors of tumor-infiltrating regulatory T cells.

Other organisations
→ Partner
Vlaams Instituut voor Biotechnologie (VIB) [Ghent, Belgium]